De-maw M. Chuang

De-maw M. Chuang's AcademicInfluence.com Rankings

De-maw M. Chuang

Physics

#5414

World Rank

#7245

Historical Rank

physics Degrees

Download Badge

Physics

De-maw M. Chuang's Degrees

PhD Physics University of California, Berkeley

Why Is De-maw M. Chuang Influential?

(Suggest an Edit or Addition)

(See a Problem?)

De-maw M. Chuang's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Multiple roles of HDAC inhibition in neurodegenerative conditions (2009) (581)
Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. (1999) (548)
Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action (2007) (504)
Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression (1999) (491)
Coupling of Inositol Phospholipid Metabolism with Excitatory Amino Acid Recognition Sites in Rat Hippocampus (1986) (470)
Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. (1998) (445)
Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction (2004) (355)
Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes (2006) (343)
Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder (2013) (342)
The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons (2009) (330)
Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation (2002) (293)
Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. (2005) (288)
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats (1998) (266)
The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain (2009) (263)
Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: An essential step for neuroprotection against glutamate excitotoxicity (2002) (258)
Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. (2008) (256)
Neuroprotective effects of lithium in cultured cells and animal models of diseases. (2002) (256)
Nuclear Factor κB Nuclear Translocation Upregulates c-Myc and p53 Expression during NMDA Receptor-Mediated Apoptosis in Rat Striatum (1999) (246)
Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity (2007) (232)
Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model (2008) (228)
Evidence that Glyceraldehyde‐3‐Phosphate Dehydrogenase Is Involved in Age‐Induced Apoptosis in Mature Cerebellar Neurons in Culture (1996) (223)
Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 Inhibition (2008) (219)
Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model (2003) (216)
The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. (2005) (211)
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. (2010) (208)
Valproic Acid Attenuates Blood–Brain Barrier Disruption in a Rat Model of Transient Focal Cerebral Ischemia: The Roles of HDAC and MMP-9 Inhibition (2011) (199)
Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation (2011) (193)
Endogenous α-Synuclein Is Induced by Valproic Acid through Histone Deacetylase Inhibition and Participates in Neuroprotection against Glutamate-Induced Excitotoxicity (2006) (190)
Down-regulation of β-adrenergic receptors following repeated injections of desmethylimipramine: Permissive role of serotonergic axons (1982) (189)
Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. (1996) (188)
Lithium Increases Transcription Factor Binding to AP‐1 and Cyclic AMP‐Responsive Element in Cultured Neurons and Rat Brain (1997) (187)
Lithium neuroprotection: molecular mechanisms and clinical implications (2004) (186)
Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases? (2004) (177)
Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. (2005) (165)
PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat (2007) (158)
Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. (1998) (157)
Regulation of c‐Jun N‐terminal kinase, p38 kinase and AP‐1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection (2003) (157)
Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome. (2011) (155)
Evidence for internalization of the recognition site of beta-adrenergic receptors during receptor subsensitivity induced by (-)-isoproterenol. (1979) (147)
GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke (2011) (146)
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder (2007) (143)
5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester. (1986) (141)
Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover (1984) (140)
Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. (1998) (139)
Regulation and Function of Glycogen Synthase Kinase-3 Isoforms in Neuronal Survival* (2006) (139)
Programmed cell death: Implications for neuropsychiatric disorders (1994) (139)
Neurotransmitter receptors and phosphoinositide turnover. (1989) (138)
Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites. (1983) (137)
Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s disease (2001) (136)
Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition (2003) (132)
Valproic acid induces functional heat‐shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation (2009) (131)
Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons (2004) (129)
Combined Treatment with the Mood Stabilizers Lithium and Valproate Produces Multiple Beneficial Effects in Transgenic Mouse Models of Huntington's Disease (2011) (128)
beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment. (2000) (127)
Nuclear Translocation of Glyceraldehyde‐3‐Phosphate Dehydrogenase Isoforms During Neuronal Apoptosis (1999) (126)
Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and p53 in Neuronal Apoptosis: Evidence That GAPDH Is Upregulated by p53 (1999) (125)
Differential Roles of Glycogen Synthase Kinase-3 Isoforms in the Regulation of Transcriptional Activation* (2006) (122)
Mesenchymal Stem Cells Primed With Valproate and Lithium Robustly Migrate to Infarcted Regions and Facilitate Recovery in a Stroke Model (2011) (120)
Phasic and tonic components in 5-HT2 receptor-mediated rat aorta contraction: participation of Ca++ channels and phospholipase C. (1985) (120)
Multiple mechanisms of serotonergic signal transduction. (1987) (120)
Bidirectional Synaptic Plasticity in the Rat Basolateral Amygdala: Characterization of an Activity-Dependent Switch Sensitive to the Presynaptic Metabotropic Glutamate Receptor Antagonist 2S-α-Ethylglutamic Acid (1998) (117)
Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury. (2012) (117)
Mechanisms of Action of Anticonvulsants in Affective Disorders: Comparisons with Lithium (1992) (116)
Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis (2017) (114)
Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease (2004) (114)
Different synaptic location of mianserin and imipramine binding sites. (1982) (113)
Inhibition of Excessive Neuronal Apoptosis by the Calcium Antagonist Amlodipine and Antioxidants in Cerebellar Granule Cells (1999) (112)
Lithium stimulates progenitor proliferation in cultured brain neurons (2003) (103)
Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2 (2005) (102)
Subcellular Distribution of Glyceraldehyde‐3‐Phosphate Dehydrogenase in Cerebellar Granule Cells Undergoing Cytosine Arabinoside‐Induced Apoptosis (1997) (99)
Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine. (1980) (96)
Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain (1995) (95)
Neuronal Apoptosis Induced by Pharmacological Concentrations of 3‐Hydroxykynurenine (2000) (94)
An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. (1996) (94)
Chronic Valproate Treatment Enhances Postischemic Angiogenesis and Promotes Functional Recovery in a Rat Model of Ischemic Stroke (2012) (94)
Lithium reduces BACE1 overexpression, β amyloid accumulation, and spatial learning deficits in mice with traumatic brain injury. (2012) (91)
N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells. (1992) (90)
A new avenue for lithium: intervention in traumatic brain injury. (2014) (88)
Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation (2016) (88)
Serotonin‐Elicited Amplification of Adenylate Cyclase Activity in Hippocampal Membranes from Adult Rat (1983) (87)
Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities (2003) (86)
Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling (2008) (86)
Overexpression of glyceraldehyde-3-phosphate dehydrogenase is involved in low K+-induced apoptosis but not necrosis of cultured cerebellar granule cells. (1997) (83)
Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury. (2013) (80)
Elevated basal and thapsigargin-stimulated intracellular calcium of platelets and lymphocytes from bipolar affective disorder patients measured by a fluorometric microassay (1999) (78)
Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists. (1987) (78)
Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells. (1996) (77)
Lithium‐induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in neuroprotection against N‐methyl‐D‐aspartate receptor‐mediated excitotoxicity (2003) (76)
Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons (2011) (75)
On the mode of action of imipramine: Relationship between serotonergic axon terminal function and down-regulation of β-adrenergic receptors (1983) (75)
FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is dramatically elevated in neurons by mood stabilizers (2013) (75)
Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery. (2013) (74)
The Mood Stabilizers Valproic Acid and Lithium Enhance Mesenchymal Stem Cell Migration via Distinct Mechanisms (2010) (73)
Neuroprotective action of lithium in disorders of the central nervous system. (2011) (73)
Biosynthesis of tyrosine hydroxylase in rat adrenal medulla after exposure to cold. (1974) (73)
Lithium Upregulates Vascular Endothelial Growth Factor in Brain Endothelial Cells and Astrocytes (2009) (73)
HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation. (2014) (72)
Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia. (2012) (71)
Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils (2007) (71)
A biochemical study of receptor internalization during beta-adrenergic receptor desensitization in frog erythrocytes. (1980) (70)
Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington’s disease (2003) (68)
Characterization of Two [3H]Ketanserin Recognition Sites in Rat Striatum (1987) (64)
Homologous Desensitization of Muscarinic Cholinergic, Histaminergic, Adrenergic, and Serotonergic Receptors Coupled to Phospholipase C in Cerebellar Granule Cells (1989) (63)
Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells. (1993) (63)
Increase in nerve growth factor content of C6 glioma cells by the activation of a β-adrenergic receptor (1977) (63)
ONO-1603, a potential antidementia drug, delays age-induced apoptosis and suppresses overexpression of glyceraldehyde-3-phosphate dehydrogenase in cultured central nervous system neurons. (1999) (60)
In Search of the Holy Grail for the Treatment of Neurodegenerative Disorders: Has a Simple Cation Been Overlooked? (2007) (59)
Antidepressant mechanism of ketamine: perspective from preclinical studies (2015) (59)
Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease (2016) (58)
The Mood Stabilizer Lithium Potentiates the Antidepressant-Like Effects and Ameliorates Oxidative Stress Induced by Acute Ketamine in a Mouse Model of Stress (2015) (57)
Serotonergic, adrenergic and histaminergic receptors coupled to phospholipase C in cultured cerebellar granule cells of rats. (1987) (56)
Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation. (1993) (55)
Characteristics and regulation of high affinity [3H]imipramine binding to rat hippocampal membranes (1981) (55)
Rat nurr1 is prominently expressed in perirhinal cortex, and differentially induced in the hippocampal dentate gyrus by electroconvulsive vs. kindled seizures. (1997) (52)
Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder (2017) (52)
Expression and Agonist‐Induced Down‐Regulation of mRNAs of m2‐ and m3‐Muscarinic Acetylcholine Receptors in Cultured Cerebellar Granule Cells (1991) (52)
Comparative studies of phosphoinositide hydrolysis induced by endothelin-related peptides in cultured cerebellar astrocytes, C6-glioma and cerebellar granule cells. (1990) (49)
Safety and efficacy of valproic acid treatment in SCA3/MJD patients. (2016) (48)
Effects of Depolarization and NMDA Antagonists on the Survival of Cerebellar Granule Cells: A Pivotal Role for Protein Kinase C Isoforms (1997) (48)
Turnover rate of tyrosine hydroxylase during Trans-synaptic induction. (1975) (48)
A role for GAPDH in apoptosis and neurodegeneration (1996) (48)
Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice. (2011) (47)
Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia (2013) (47)
Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions. (2013) (47)
Neurotrophins protect against cytosine arabinoside-induced apoptosis of immature rat cerebellar neurons (2005) (46)
Downregulated AEG-1 together with inhibited PI3K/Akt pathway is associated with reduced viability of motor neurons in an ALS model (2015) (45)
Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models (2011) (45)
Novel integrative genomic tool for interrogating lithium response in bipolar disorder (2015) (45)
Genetic disruption of ankyrin-G in adult mouse forebrain causes cortical synapse alteration and behavior reminiscent of bipolar disorder (2017) (44)
Carbamazepine induction of apoptosis in cultured cerebellar neurons: effects ofN-methyl-d-aspartate, aurintricarboxylic acid and cycloheximide (1995) (43)
Different signal transduction pathways are coupled to the nucleotide receptor and the P2Y receptor in C6 glioma cells. (1994) (43)
Prostaglandin A(1) protects striatal neurons against excitotoxic injury in rat striatum. (2001) (41)
Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction. (2013) (41)
Differential down-regulation of β1- and β2-adrenergic receptor mRNA in C6 glioma cells (1990) (40)
Preclinical and Clinical Investigations of Mood Stabilizers for Huntington's Disease: What Have We Learned? (2014) (39)
Modulation by calcium of gamma-aminobutyric acid (GABA) binding to GABAA and GABAB recognition sites in rat brain. Involvement of different mechanisms. (1984) (38)
Inhibitors of transglutaminase prevent agonist-mediated internalization of beta-adrenergic receptors. (1981) (37)
miR‐25 alleviates polyQ‐mediated cytotoxicity by silencing ATXN3 (2014) (37)
Functional MRI of Delayed Chronic Lithium Treatment in Rat Focal Cerebral Ischemia (2008) (36)
Transfer of ADP-ribose from NAD to choleragen: a subunit acts as catalyst and acceptor protein. (1977) (36)
Carbachol-induced accumulation of inositol-1-phosphate in neurohybridoma NCB-20 cells: effects of lithium and phorbol esters. (1986) (35)
Potent neuroprotective effects of novel structural derivatives of valproic acid: Potential roles of HDAC inhibition and HSP70 induction (2010) (35)
Modulation of calcium uptake and D-aspartate release by GABAB receptors in cultured cerebellar granule cells. (1987) (34)
Co-stimulation of cyclic-AMP-linked metabotropic glutamate receptors in rat striatum attenuates excitotoxin-induced nuclear factor-κB activation and apoptosis (1999) (34)
Endothelin- and sarafotoxin-induced phosphoinositide hydrolysis in cultured cerebellar granule cells: biochemical and pharmacological characterization. (1991) (34)
Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity (2005) (32)
Studies on elongation factor II from calf brain. (1972) (32)
Characterization of Bradykinin‐Induced Phosphoinositide Turnover in Neurohybrid NCB‐20 Cells (1988) (32)
Differences in the regulatory adaptation of the 5HT2 recognition sites labelled by 3H-mianserin or 3H-ketanserin (1983) (32)
Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilience (2011) (31)
Cross-desensitization of endothelin- and sarafotoxin-induced phosphoinositide turnover in neurons. (1989) (31)
Daily bupropion injections for 3 weeks attenuate the ne-stimulation of adenylate cyclase and the number of β-adrenergic recognition sites in rat frontal cortex (1983) (31)
Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3 (2016) (31)
Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone. (1991) (30)
Protein kinase activation as an early event in the trans-synaptic induction of tyrosine 3-monooxygenase in adrenal medulla. (1975) (30)
PET imaging with [ 11 C ] PBR 28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat (2006) (30)
Long-term biphasic effects of lithium treatment on phospholipase C-coupled m3-muscarinic acetylcholine receptors in cultured cerebellar granule cells (1993) (30)
A translocation-associated ribosomal conformational change detected by hydrogen exchange and sedimentation velocity. (1971) (30)
Nuclear factor‐κB‐dependent cyclin D1 induction and DNA replication associated with N‐methyl‐D‐aspartate receptor‐mediated apoptosis in rat striatum (2007) (28)
Endothelin- and ATP-induced inhibition of adenylyl cyclase activity in C6 glioma cells: role of Gi and calcium. (1993) (28)
Is insulin a neuromodulator? (1982) (27)
Transplantation of Mesenchymal Stem Cells Overexpressing FGF21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury. (2019) (27)
Enhanced template activity in chromatin from adrenal medulla after phosphorylation of chromosomal proteins. (1976) (27)
Role of second messengers in agonist up-regulation of 5-HT2A (5-HT2) receptor binding sites in cerebellar granule neurons: involvement of calcium influx and a calmodulin-dependent pathway. (1995) (27)
Fluoxetine modulates G protein αs, αq and α12 subunit mRNA expression in rat brain (1992) (26)
GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons (2018) (26)
Chronic buspirone treatment differentially regulates 5-HT1A and 5-HT2A receptor mRNA and binding sites in various regions of the rat hippocampus. (1995) (25)
Carbamazepine-induced neurotoxicity and its prevention by NMDA in cultured cerebellar granule cells (1992) (25)
Endothelin-induced activation of phosphoinositide turnover, calcium mobilization, and transmitter release in cultured neurons and neurally related cell types. (1991) (24)
Endothelin-1 stimulates the release of preloaded [3H]D-aspartate from cultured cerebellar granule cells. (1990) (23)
Neurotrophin Protection Against Toxicity Induced by Low Potassium and Nitroprusside in Cultured Cerebellar Granule Neurons (1997) (21)
Potential use of lithium in neurodegenerative disorders (2006) (21)
5-hydroxytryptamine2A receptor stimulation induces activator protein-1 and cyclic AMP-responsive element binding with cyclic AMP-responsive element-binding protein and jun D as common components in cerebellar neurons (1999) (20)
ONO-1603, a potential antidementia drug, shows neuroprotective effects and increases m3-muscarinic receptor mRNA levels in differentiating rat cerebellar granule neurons (1996) (20)
Regulation of β‐Adrenergic Receptor mRNA in Rat C6 Glioma Cells Is Sensitive to the State of Microtubule Assembly (1994) (19)
Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cells. (1995) (19)
Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells. (1992) (18)
Trans-synaptic regulation of ribonucleic acid biosynthesis in rat adrenal medulla. (1976) (16)
Internalization of beta-adrenergic receptor binding sites: involvements of lysosomal enzymes. (1982) (16)
Regulation of bradykinin-induced phosphoinositide turnover in cultured cerebellar astrocytes: possible role of protein kinase C (1992) (16)
The Antiapoptotic Actions of Mood Stabilizers (2005) (16)
Protein phosphorylation in nuclei of adrenal medulla incubated with cyclic adenosine 3':5'-monophosphate-dependent protein kinase. (1977) (16)
Tetrahydroaminoacridine is neurotrophic and promotes the expression of muscarinic receptor-coupled phosphoinositide turnover in differentiating cerebellar granule cells. (1993) (15)
GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE ,A POPTOSIS, AND NEURODEGENERATIVE DISEASES ∗ (2005) (14)
Hippocampal distribution of acetylcholine, muscarinic receptors and cyclic GMP (1980) (13)
Splice variants of rat TR4 orphan receptor: differential expression of novel sequences in the 5'-untranslated region and C-terminal domain. (1996) (13)
Inhibition of Excitatory Amino Acid‐Induced Phosphoinositide Hydrolysis as a Possible Mechanism of Nitroprusside Neurotoxicity (1996) (13)
Agonist-induced desensitization of ATP receptor-mediated phosphoinositide turnover in C6 glioma cells: Comparison with the negative-feedback regulation by protein kinase C (1993) (13)
The mitochondrial hypothesis of bipolar disorder. (2000) (13)
Differential Regulation by Butyrate and Dibutyryl Cyclic AMP of δ‐Opioid, α2‐Adrenergic, and Muscarinic Cholinergic Receptors in NCB‐20 Cells (1988) (12)
Extracellular ATP stimulates inositol phospholipid turnover and calcium influx in C6 glioma cells (1993) (12)
12 – Mechanism of Action of Lithium: Comparison and Contrast with Carbamazepine (1991) (11)
Rebound increase of basal cAMP level in NG108-15 cells during chronic morphine treatment: effects of naloxone and chloramphenicol. (1989) (11)
Overexpression of fibroblast growth factor‐21 (FGF‐21) protects mesenchymal stem cells against caspase‐dependent apoptosis induced by oxidative stress and inflammation (2020) (11)
Fluoxetine modulates G protein alpha s, alpha q, and alpha 12 subunit mRNA expression in rat brain. (1992) (11)
Benzodiazepines enhance the muscimol-dependent activation of phospholipase A2 in glioma C6 cells. (1985) (11)
Characterization of typical and atypical antidepressant recognition sites in rat brain. (1982) (10)
Translocation of cytosol protein kinase into nuclei and the induction of tyrosine hydroxylase in NBD-2 neuroblastoma cells (1979) (10)
GABA pretreatment enhances glutamate mediated phosphoinositide hydrolysis in neurons. (1988) (10)
Chronic haloperidol treatment attenuates receptor-mediated phosphoinositide turnover in rat brain slices (1991) (10)
Lithium protection from glutamate excitotoxicity: therapeutic implications (2004) (10)
[Neuroprotective actions of lithium]. (2003) (10)
Cross-linking of [125I]-endorphin to -opioid receptors during development (1989) (9)
Endothelin‐1 increases the levels of mRNA and protein of muscarinic acetylcholine receptors and c‐fos mRNA in cerebellar granule cells (1994) (9)
Roles of Glycogen Synthase Kinase-3 in Alzheimer's Disease: From Pathology to Treatment Target (2012) (9)
Characterization of two distinct 5-HT receptors coupled to adenylate cyclase activation and ion current generation in NCB-20 cells (1990) (9)
Nuclear translocation of catalytic subunits of cytosol cAMP-dependent protein kinase in the transsynaptic induction of medullary tyrosine hydroxylase. (1978) (8)
m2- and m3-muscarinic acetylcholine receptor mRNAs have different responses to microtubule-affecting drugs (1991) (8)
5‐Hydroxytryptamine Uptake and Imipramine Binding Sites in Neurotumor NCB‐20 Cells (1985) (8)
Role of microtubule structure in the maintenance of m3-muscarinic acetylcholine receptor rnRNA levels (1991) (7)
Maitotoxin Induces Phosphoinositide Turnover and Modulates Glutamatergic and Muscarinic Cholinergic Receptor Function in Cultured Cerebellar Neurons (1990) (7)
Specific binding of [3H]mianserin and [3H]imipramine to structures of rat hippocampus. (1982) (7)
Tetrahydroaminoacridine increases m3-, but not m2-, muscarinic acetylcholine receptor mRNA levels in differentiating cerebellar granule cells (1993) (6)
Substrates for protein kinase C in a cell free preparation of rat aorta smooth muscles. (1988) (6)
beta-Adrenergic receptors from frog erythrocytes: receptor internalization as a mechanism for receptor desensitization. (1980) (6)
Autoradiographic demonstration of an increase in muscarinic cholinergic receptors in cerebellar granule cells treated with tetrahydroaminoacridine (1993) (6)
beta-Adrenergic receptors of frog erythrocytes. Biochemical sequelae following stimulation with isoproterenol. (1979) (6)
Polypeptide Hormones and Chromatin‐Associated Proteins Act as Acceptors for Cholera Toxin‐Catalyzed ADP‐Ribosylation (1981) (6)
Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction. (2014) (6)
Comparison of the butyrate effects on neurotransmitter receptors in neurohybrids NG108-15 and NCB-20 cells. (1987) (5)
Recognition Sites for Antidepressant Drugs (1984) (5)
Potentiation by Ca2+ ionophores and inhibition by extracellular KCl of endothelin-induced phosphoinositide turnover in C6 glioma cells (1992) (5)
Expression of neurotrophic activity in Xenopus oocytes injected with mRNA from wounded rat cerebral cortex. (1990) (5)
Effects of chronic nicotine and haloperidol administration on muscarinic receptor-mediated phosphoinositide turnover in rat brain slices (2005) (5)
Trans-synaptic mechanisms in the action of imipramine (1983) (4)
Tryptamine Induces Phosphoinositide Turnover and Modulates Adrenergic and Muscarinic Cholinergic Receptor Function in Cultured Cerebellar Granule Cells (1994) (4)
Ethanol induces subtype-specific up-regulation of muscarinic acetylcholine receptor mRNA in neurohybrid cell lines. (1997) (4)
Molecular mechanisms in the action of imipramine (1983) (4)
β-adrenergic receptor internalization and processing: role of transglutaminase and lysosomes (2004) (4)
Ibotenic acid stimulates inositol phospholipid turnover in rat hippocampal slices: An effect mediated by 'APB-sensitive' receptors (1985) (4)
Differential effects of butyrate and dibutyryl cAMP on mRNA levels of muscarinic acetylcholine receptor subtypes expressed in neurohybrid cell lines (1996) (4)
The role of ribosomal conformation in protein synthesis: conformational changes in the ribosome during the tranlocation step. (1971) (4)
Effect of cocaine, lidocaine kindling and carbamazepine on batrachotoxin-induced phosphoinositide hydrolysis in rat brain slices (1993) (4)
Long‐Term GABA Treatment Elicits Supersensitivity of Quisqualate‐Preferring Metabotropic Glutamate Receptor in Cultured Rat Cerebellar Neurons (1993) (4)
Characterization of 5-HT2 receptors linked to phospholipase C in rat aorta (1985) (3)
PUTATIVE ENDOGENOUS LIGANDS FOR ANTIDEPRESSANT RECOGNMON SITES (1984) (3)
Differential down-regulation of beta 1- and beta 2-adrenergic receptor mRNA in C6 glioma cells. (1990) (3)
β-Adrenergic receptors of frog erythrocytes (1979) (3)
Differential regulation by butyrate and dibutyryl cyclic AMP of delta-opioid, alpha 2-adrenergic, and muscarinic cholinergic receptors in NCB-20 cells. (1988) (3)
Effects of up-regulation by butyrate on delta opioid receptor GTP sensitivity and distribution in subcellular compartments. (1990) (2)
Corrigendum: Chronic buspirone treatment differentially regulates 5-HT(1A) and 5-HT(2A) receptor mRNA and binding sites in various regions of the rat hippocampus (Molecular Brain Research (1995) 32 (348-353)) (1996) (2)
Evidence for an endacoid for the 5HT2 recognition site. (1985) (2)
Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19. (2022) (2)
Control of Nuclear Function in Chromaffin Cells by Persistent Activation of Nicotinic Receptors (1978) (2)
Effect of eukaryote DNA on amino acid incorporation in extracts of E. coli. (1973) (2)
Valproic Acid and Other HDAC Inhibitors Induce Microglial Apoptosis and Attenuate Lipopolysaccharide- induced Dopaminergic Neurotoxicity (2009) (2)
Antagonists have a greater selectivity for muscarinic receptor subtypes in intact cerebellar granule cells than in membranes (1996) (2)
Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices (1994) (2)
Electroacupuncture improves TBI dysfunction by targeting HDAC overexpression and BDNF-associated Akt/GSK-3β signaling (2022) (1)
Assessment of lithium treatment using fMRI during stroke recovery in rats (2005) (1)
Characterization of protein kinases from adrenal medulla (1978) (1)
A monoclonal antibody to a membrane component that interacts with the beta-adrenergic receptor. (1985) (1)
Cross-linking of [125I]beta-endorphin to mu-opioid receptors during development. (1989) (1)
Lithium exerts robust neuroprotective effects in vitro and in the CNS in vivo Therapeutic implications (2000) (1)
S-34-4 Opposing effects of stress andantidepressants of neurotrophic factors (1996) (1)
Soluble and membrane-bound protein kinases in newborn and mature rat brain. (1979) (1)
Changes in immunohistochemical properties of beta-adrenergic receptors in frog erythrocytes by isoproterenol-induced desensitization. (1988) (1)
Neuroprotection against Apoptosis (2003) (1)
Regulation by batrachotoxin, veratridine, and monensin of basal and carbachol-induced phosphoinositide hydrolysis in neurohybrid NCB-20 cells (1990) (1)
Atypical Neuroanatomy and Intrinsic Functional Connectivity as an Intermediate Imaging Phenotype for Autism Spectrum Disorder (2015) (0)
Mechanisms of lithium ’ s neuroprotective actions 2 . 1 Lithium as a multi-functional neuroprotectant (2011) (0)
Transsynaptic regulation of nuclear RNA synthesis in adrenal medulla of rats exposed to cold. (1976) (0)
REGULATION OF NOREPINEPHRINE-MEDIATED VASCULAR CONTRACTILITY (1985) (0)
Mechanisms of the internalization of ß-adrenergic receptor recognition sites (1981) (0)
Modification of morphine effects on basal cyclic amp level in ng108 15 cells (1988) (0)
Carbachol-induced phosphoinositide turnover in NCB-20 cells (1986) (0)
Emerging Role of Lithium as a Neuroprotective Drug (2001) (0)
5HT and 5HT2 recognition sites are present in the 5HT receptor complex of NCB-20 cell line (1984) (0)
Editorial Board (2009) (0)
Molecular biology of tyrosine hydroxylase induction (1981) (0)
Introduction to effector-coupled cell surface receptors. (1989) (0)
Possible Involvement of Bax Inhibitor 1 (BI-1), A Modulator for Endoplasmic Reticulum (ER) Cellular Stress, in Affective Resilience (2010) (0)
On a bovine brain peptide functioning as a putative ligand for 5HT2 recognition sites (1984) (0)
Streptomycin and ribosome conformation changes. (1969) (0)
Preventing the Sequelae of Concussions and Traumatic Brain Injury (2014) (0)
Regulation of effector-coupled receptors in cultured cerebellar granule cells (1990) (0)
PET imaging of cerebral ischemia with a peripheral benzodiazepine receptor ligand (2006) (0)
44 – NUCLEAR TRANSLOCATION OF cAMP-DEPENDENT PROTEIN KINASE (PK) AND THE INDUCTION OF TYROSINE HYDROXYLASE (TH) IN NEUROBLASTOMA CELLS (1978) (0)
Evidence for internalization of the recognition site of f 3-adrenergic receptors during receptor subsensitivity induced by (-)-isoproterenol ( receptor desensitization / receptor internalization / frog erythrocytes / adenylate cyclase ) (0)
Original Articles Transplantation of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury (2019) (0)
Serotonin-stimulated protein phosphorylation in aortic smooth muscle cells (1989) (0)
Combinatory treatment with mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease (2011) (0)
5HT/sub 2/ receptors coupled to phospholipase C in rat aorta are modulated by phorbol esters (1986) (0)
Further studies on eukaryote DNA stimulation of amino acid incorporation in E. coli extracts. (1974) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With De-maw M. Chuang?

De-maw M. Chuang is affiliated with the following schools:

Josai University